Emily Rayens

693 total citations · 1 hit paper
27 papers, 412 citations indexed

About

Emily Rayens is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emily Rayens has authored 27 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 10 papers in Infectious Diseases and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emily Rayens's work include Pneumocystis jirovecii pneumonia detection and treatment (9 papers), Antifungal resistance and susceptibility (7 papers) and Fungal Infections and Studies (6 papers). Emily Rayens is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (9 papers), Antifungal resistance and susceptibility (7 papers) and Fungal Infections and Studies (6 papers). Emily Rayens collaborates with scholars based in United States and France. Emily Rayens's co-authors include Karen A. Norris, Mary Kay Rayens, Amanda T. Wiggins, José F. Cordero, Whitney Rabacal, Ellen J. Hahn, Melody Noland, Finja Schweitzer, Amanda Fallin and Kristin Ashford and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Emily Rayens

26 papers receiving 401 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018

2022 134 citations Emily Rayens, Karen A. Norris profile →

Peers

Countries citing papers authored by Emily Rayens

Since Specialization

Citations

This map shows the geographic impact of Emily Rayens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Rayens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Rayens more than expected).

Fields of papers citing papers by Emily Rayens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Rayens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Rayens. The network helps show where Emily Rayens may publish in the future.

Co-authorship network of co-authors of Emily Rayens

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Rayens. A scholar is included among the top collaborators of Emily Rayens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Rayens. Emily Rayens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study 2025 ·Annals of the Rheumatic Diseases ·Emily Rayens, Lina S. Sy, Lei Qian, Jun Wu, Bradley K. Ackerson, Yi Luo, (unknown), Aimee Bence Lin, Zendi Solano, (unknown), (unknown), Ana Florea, Jennifer H Ku, (unknown), Driss Oraichi, Harry Seifert, Huifeng Yun, Hung Fu Tseng	1
2	Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years 2025 ·Clinical Infectious Diseases ·Emily Rayens, Lina S. Sy, Lei Qian, Jun Wu, Bradley K. Ackerson, Yi Luo, Chengyi Zheng, (unknown), (unknown), (unknown), Harpreet S. Takhar, Jennifer H Ku, (unknown), Huifeng Yun, Driss Oraichi, Harry Seifert, Hung Fu Tseng	0
3	Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States 2025 ·Clinical Infectious Diseases ·Hung Fu Tseng, Lina S. Sy, Bradley K. Ackerson, Emily Rayens, Jun Wu, Yi Luo, (unknown), Jennifer H Ku, (unknown), Harpreet S. Takhar, (unknown), Rachel Cohen, Huifeng Yun, Driss Oraichi, Harry Seifert, Lei Qian	1
4	Protective efficacy of the pan-fungal vaccine NXT-2 against vulvovaginal candidiasis in a murine model 2025 ·npj Vaccines ·(unknown), Toni A. Chapman, Emily Rayens, Whitney Rabacal, Hubertine M. E. Willems, (unknown), Brian M. Peters, Karen A. Norris	4
5	Comparative Effectiveness of Cell‐Based Versus Egg‐Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022–2023 Season Among Adults 18–64 Years 2024 ·Influenza and Other Respiratory Viruses ·Emily Rayens, Jennifer H Ku, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Julia E. Tubert, Gina S. Lee, (unknown), Yoonyoung Park, (unknown), Evan J. Anderson, Hung Fu Tseng	2
6	Estimating mortality in chronic pulmonary aspergillosis 2024 ·The Lancet Infectious Diseases ·Emily Rayens	1
7	Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022–2023 Influenza Season Among Adults ≥65 Years of Age 2024 ·Clinical Infectious Diseases ·Jennifer H Ku, Emily Rayens, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Julia E. Tubert, Gina S. Lee, (unknown), Yoonyoung Park, (unknown), Evan J. Anderson, Hung Fu Tseng	2
8	Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis 2022 ·PNAS Nexus ·Emily Rayens, Whitney Rabacal, Hubertine M. E. Willems, (unknown), James Barber, Jarrod J. Mousa, (unknown), Michelle Momany, Karen A. Norris	20
9	A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection 2022 ·Frontiers in Immunology ·Whitney Rabacal, Finja Schweitzer, Heather M. Kling, (unknown), Emily Rayens, Karen A. Norris	7
10	Mortality Trends in Risk Conditions and Invasive Mycotic Disease in the United States, 1999–2018 2021 ·Clinical Infectious Diseases ·Emily Rayens, Karen A. Norris, José F. Cordero	42
11	Relationship of Pneumocystis antibody responses to paediatric asthma severity 2021 ·BMJ Open Respiratory Research ·Emily Rayens, (unknown), Alfin G. Vicencio, David L. Goldman, Supinda Bunyavanich, Karen A. Norris	10
12	Vaccine-Induced Protection in Two Murine Models of Invasive Pulmonary Aspergillosis 2021 ·Frontiers in Immunology ·Emily Rayens, Whitney Rabacal, Sungkwon Kang, (unknown), Michelle Momany, Karen A. Norris	12
13	The Gene CG6767 Affects Olfactory Behavior in Drosophila melanogaster 2019 ·Behavior Genetics ·Elizabeth Brown, Emily Rayens, Stephanie M. Rollmann	2
14	Statin treatment prevents the development of pulmonary arterial hypertension in a nonhuman primate model of HIV-associated PAH 2019 ·Scientific Reports ·Whitney Rabacal, Finja Schweitzer, Emily Rayens, (unknown), (unknown), Viviana Cobos Jiménez, (unknown), Karen A. Norris	10
15	Immunization with Pneumocystis recombinant KEX1 induces robust and durable humoral responses in immunocompromised non-human primates 2019 ·Human Vaccines & Immunotherapeutics ·Viviana Cobos Jiménez, Whitney Rabacal, Emily Rayens, Karen A. Norris	10
16	Longitudinal Evaluation of Pulmonary Arterial Hypertension in a Rhesus Macaque (Macaca mulatta) Model of HIV Infection 2018 ·Comparative Medicine ·(unknown), Finja Schweitzer, Marc A. Simon, Rebecca Vanderpool, (unknown), Emily Rayens, Heather M. Kling, (unknown), Jonathan Carney, Brian J. Lopresti, Thomas Bertero, Stephen Y. Chan, Karen A. Norris	9
17	Monocyte and Alveolar Macrophage Skewing Is Associated with the Development of Pulmonary Arterial Hypertension in a Primate Model of HIV Infection 2018 ·AIDS Research and Human Retroviruses ·Finja Schweitzer, (unknown), Emily Rayens, Heather M. Kling, Joshua T. Mattila, Karen A. Norris	20
18	<em>Pneumocystis</em> as a Co-Factor in Pulmonary Diseases 2018 ·Whitney Rabacal, Emily Rayens, Karen A. Norris	2
19	Current Use of E-Cigarettes and Conventional Cigarettes Among US High School Students in Urban and Rural Locations: 2014 National Youth Tobacco Survey 2017 ·American Journal of Health Promotion ·Melody Noland, Mary Kay Rayens, Amanda T. Wiggins, (unknown), Emily Rayens, (unknown), Ellen J. Hahn	33
20	Advertising exposure and use of e‐cigarettes among female current and former tobacco users of childbearing age 2017 ·Public Health Nursing ·Kristin Ashford, Emily Rayens, Amanda T. Wiggins, Mary Kay Rayens, Amanda Fallin, (unknown)	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact